8 Tips for Taking the Internal Medicine Boards

July 19, 2022

What you need is to combine the knowledge you've acquired with a solid test-taking strategy to be successful.

Read Post

Is it Enough to Just Learn the Blueprint Topics?

July 12, 2022

K2P products meet the needs and interests of our physician learners. And not just the need to master the basics of disease X or Y, but the desire to meet each patient where they are to provide true healing. 

ACC/AHA Issue Report for CV and Non-CV Complications of COVID-19

June 30, 2022

The American College of Cardiology/American Heart Association ​​Task Force on Clinical Data Standards published a report June 23 listing and defining key data elements related to cardiovascular and noncardiovascular complications of COVID-19. 

The TL;DR on the ABIM LKA

June 1, 2022

Instead of sitting for the traditional 10-year MOC exam, LKA participants choose when and where to answer assessment questions, find out in real-time if they were right or wrong, and receive a rationale and references to provide context and enhance learning. 

Dr. Michelle Kittleson – Advanced Heart Failure & Transplantation

May 19, 2022

The world of advanced heart failure is relatively small and specialized, but the most important thing learners should know is when to identify a patient who's heading down that slippery slope of advanced heart failure.

Focus on K2P Faculty: Dr. George Bakris

May 12, 2022

Dr. Bakris has been extensively involved as either a principal investigator or on the steering committees of national and international trials involving diabetic kidney disease progression and resistant hypertension. There are many people with different types of hypertension, isolated, systolic, masked, and white coat hypertension. Continue reading...

How to Pass the ECG and Imaging Section of the Cardiology Board Exam

May 4, 2022

Are you prepared for the ECG and Imaging Studies component of the Cardiology Board Exam? 

ACC 2022: Update on Mavacamten for Obstructive Hypertrophic Cardiomyopathy

April 29, 2022

Mavacamten had a big week at the American College of Cardiology 2022 Scientific Sessions, with two positive Late-Breaking Clinical Trial sessions.  Mavacamten is an investigational, ​first-in-class, cardiac-specific myosin inhibitor that reduces the number of available actin-myosin cross-bridges and thus decreases excessive myocardial contractility.

Focus on K2P Faculty: Neil Stone

April 12, 2022

Dr. Neil Stone serves as faculty for K2P’s LEGENDS series, where he has provided a talk on the prevention of cardiovascular disease through lipid management.

ACC 2022: Novel Gene-Silencing Therapy Cuts Lp(a) by 98%

April 11, 2022

Among the top-notch research presented at the American College of Cardiology 2022 Scientific Sessions was a small phase 1 trial that demonstrated big potential for a therapeutic that will lower lipoprotein [Lp(a)] and reduce atherosclerotic risk. 

Electrophysiology Cardiology Legend Dr. Hugh Calkins Interview

April 4, 2022

Dr. Hugh Calkins is a member of the K2P Legends Series faculty and has provided a video entitled “Electrophysiology: State of the Science.” 

Coronary Artery Disease – Cardiology LEGEND Dr. Deepak Bhatt Explains

April 4, 2022

Dr. Deepak Bhatt serves as faculty for K2P’s LEGENDS series, where he has provided a retrospective on coronary artery disease. He also contributes regularly to other K2P activities, providing education and an expert perspective to many of our programs. 

Q&A with Dr. Ty Gluckman – CurrentMD Cardiology

March 31, 2022

Dr. Ty Gluckman is the Curriculum Chair for K2P’s CurrentMD™ Cardiology product, where he helps to strategize and oversee the cardiology curriculum. He also contributes regular content on a variety of topics, including evaluation of chest pain and risk factor assessment.

1 of 8